InvestorsHub Logo
Followers 737
Posts 76033
Boards Moderated 0
Alias Born 01/01/2012

Re: zombywolf post# 124176

Tuesday, 12/26/2017 7:10:04 PM

Tuesday, December 26, 2017 7:10:04 PM

Post# of 203913
That is how OTCM share selling schemes work - promise the psoriasis cream - efficacy report - safety study - don't publish any information then start dangling a new carrot in front of the shareholders.

Here is the latest carrot:

"OWC Pharmaceutical Research Corp. Announces Update on its Proprietary Medical Cannabis Sublingual Tablet"

"In December 2017, OWC Pharmaceutical Research Corp (OTCQB: OWCP) received a new permit from the Israel Medical Cannabis Agency [MCA] to proceed with the safety study of their oral disintegrating tablet. The study protocol will be submitted to the Institutional Review Board [IRB] at a leading Israeli academic hospital in the coming weeks."

Now the psoriasis cream giddiness (carrot) will be moved to the Sublingual Tablet giddiness (carrot).

IG




"The Hour Between Dog and Wolf"